Huili Xu Selected Research

Cyclodextrins

12/2020

Cyclodextrin-mediated formation of porous RNA nanospheres and their application in synergistic targeted therapeutics of hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huili Xu Research Topics

Disease

5	Neoplasms (Cancer) 01/2021 - 11/2004
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 11/2004
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 12/2020
1	Giant Cell Tumor of Tendon Sheath 01/2019
1	Lung Injury 02/2015

Drug/Important Bio-Agent (IBA)

1	TeaIBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	tryptoline (tetrahydronorharmane)IBA 12/2020
1	2,3-trimethylene-4-quinazoloneIBA 12/2020
1	AcetylcholinesteraseIBA 12/2020
1	Amyloid (Amyloid Fibrils)IBA 12/2020
1	Peptides (Polypeptides)IBA 12/2020
1	CyclodextrinsIBA 12/2020
1	Sorafenib (BAY 43-9006)FDA Link 12/2020
1	RNA (Ribonucleic Acid)IBA 12/2020
1	Epithelial Cell Adhesion MoleculeIBA 12/2020
1	Small Interfering RNA (siRNA)IBA 12/2020
1	CollagenIBA 08/2020
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Macrophage Colony-Stimulating FactorIBA 01/2019
1	Free RadicalsIBA 02/2015
1	Oxygen (Dioxygen)IBA 02/2015
1	CytokinesIBA 02/2015
1	Complementary DNA (cDNA)IBA 11/2004

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 12/2020
1	Therapeutics 12/2020
1	Nanospheres 12/2020